Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery

被引:38
|
作者
Fan Li-Fang [2 ,3 ]
He Wei [1 ,4 ]
Chang Yong-Zhen [7 ,8 ]
Xiang Bai [1 ]
Du Qing [1 ]
Wang Feng [5 ]
Qin Min [6 ]
Cao De-Ying [1 ]
机构
[1] Hebei Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut Anal, Shijiazhuang, Peoples R China
[3] Inst Med, Hebei Yiling Pharmaceut Grp, Beijing, Peoples R China
[4] CSPC Pharmaceut Technol Co Ltd, Shijiazhuang, Peoples R China
[5] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Hepatitis, Beijing, Peoples R China
[6] Liuzhou Worker Hosp, Dept Gastroenterol, Liuzhou, Peoples R China
[7] XingTai Med Coll, XingTai Med Sch Facial Feature, Dept Pharmaceut, Xingtai, Peoples R China
[8] XingTai Med Coll, Med Treatment Tech Fac, Xingtai, Peoples R China
关键词
Chitosan; Kollicoat SR30D; Film coating; Colonic delivery; Pharmacokinetics; IN-VITRO EVALUATION; 5-AMINOSALICYLIC ACID; TARGETED DELIVERY; CHITOSAN; RELEASE; AMYLOSE; PELLETS; VIVO; POLYSACCHARIDES; BACTERIA;
D O I
10.1016/j.ijpharm.2009.03.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to define in vitro and in vivo characteristics of chitosan/Kollicoat SR30D film-coated tablets of theophylline for colonic delivery. The tablet cores were coated to different film thicknesses with blends of Kollicoat SR30D and chitosan (2.51, 3.5:1, and 5:1, w/w). Swelling and drug release studies were carried out in simulated gastric fluid, simulated intestinal fluid and simulated colonic fluid, respectively. The mechanism of drug release was determined using the Korsmeyer-Peppas model. The in vivo degradation of the tablets was also studied in rats. The swelling behavior and drug release depended on the composition of the coating, as well as the ratio of Kollicoat SR30D to chitosan. The coating was susceptible to enzymatic action, and more accessible to bacterial enzymes than beta-glucosiclase enzyme. The extent of swelling and digestion correlated with the amount of chitosan within the coating. The drug release data fit well into the Korsmeyer-Peppas equation, indicating that the drug release was controlled by polymer relaxation. The in vivo pharmacokinetic studies of the coated tablets showed delayed T-max, decreased C-max and prolonged MRT. Chitosan/Kollicoat SR30D coated tablets could deliver the drug to the targeted site for local action. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 30 条
  • [21] Development of Fluoride-Loaded Chitosan Microparticles for Controlled Drug Delivery: A Comparative Study of PVP K17 and Eudragit® RS 30D as Coating Polymer
    Fookes, Federico A.
    Velazquez, Natalia S.
    Rigalli, Alfredo
    Luna, Julio A.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2023, 18 (04) : 1941 - 1953
  • [22] Gamma scintigraphic studies on guar gum-based compressed coated tablets for colonic delivery of theophylline in healthy volunteers
    Celkan, Armagan
    Acarturk, Fusun
    Tugcu-Demiroz, Fatmanur
    Gokcora, Nahide
    Akkas, Burcu Esen
    Guner, Levent A.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2016, 32 : 31 - 37
  • [23] Solvent-Cast Polymeric Films from Pectin and Eudragit(R) NE 30D for Transdermal Drug Delivery Systems
    Suksaeree, Jirapornchai
    Maneewattanapinyo, Pattwat
    Panrat, Kamon
    Pichayakorn, Wiwat
    Monton, Chaowalit
    JOURNAL OF POLYMERS AND THE ENVIRONMENT, 2021, 29 (10) : 3174 - 3184
  • [24] Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery
    Freire, Cristina
    Podczeck, Fridrun
    Ferreira, Dinora
    Veiga, Francisco
    Sousa, Joao
    Pena, Angelina
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (01) : 55 - 61
  • [25] Influence of plasticizer concentration and storage conditions on the drug release rate from Eudragit(R) RS30D film-coated sustained-release theophylline pellets
    Amighi, K
    Moes, A
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1996, 42 (01) : 29 - 35
  • [26] Studies of pectin HM/Eudragit® RL/Eudragit® NE film-coating formulations intended for colonic drug delivery
    Semdé, R
    Amighi, K
    Devleeschouwer, MJ
    Moës, AJ
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 197 (1-2) : 181 - 192
  • [27] Formulation development, optimization and study on drug release kinetics of Eudragit((R)) L100-HPMC E15 LV mixed film-coated colon-targeted Mesalamine tablets
    Newton, A. Maria John
    Prabakaran, L.
    Jayaveera, K. N.
    ASIAN JOURNAL OF PHARMACEUTICS, 2012, 6 (03) : 180 - 189
  • [28] Chitosan coated copper/silver oxide nanoparticles as carriers of breast anticancer drug: Cyclin D1/P53 expressions and cytotoxicity studies
    Rahimi, Elena
    Asefi, Farzaneh
    Afzalinia, Ahmadreza
    Khezri, Somayeh
    Zare-Zardini, Hadi
    Ghorani-Azam, Adel
    Es-haghi, Ali
    Yazdi, Mohammad Ehsan Taghavizadeh
    INORGANIC CHEMISTRY COMMUNICATIONS, 2023, 158
  • [29] Influence of curing conditions on the drug release rate from Eudragit NE30D film coated sustained-release theophylline pellets
    Amighi, K
    Moes, AJ
    STP PHARMA SCIENCES, 1997, 7 (02): : 141 - 147
  • [30] A pH/enzyme-responsive polymer film consisting of Eudragit® FS 30 D and arabinoxylane as a potential material formulation for colon-specific drug delivery system
    Rabito, Mirela Fulgencio
    Reis, Adriano Valim
    Freitas, Adonilson dos Reis
    Tambourgi, Elias Basile
    Cavalcanti, Osvaldo Albuquerque
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2012, 17 (04) : 429 - 436